News

The 3-D atomic structure of an ion channel found in mammals that is implicated in a rare, inherited neurodegenerative disease in humans has been solved,

The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.

$1 million research grant could lead to life-saving antibiotics.

Industry expert Peter Llewellyn-Davies joins as New Chief Financial Officer.

Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

Improved understanding of emulsions for separating rare earths could aid the removal of radioactive metals and nuclear waste.

The Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a Phase 1 clinical trial in humans for a promising leprosy vaccine candidate – the first vaccine developed specifically for leprosy.

Researchers from Radboud University have found more than 30,000 publications are reporting on the wrong cells.

Scientists have used cellular drug screening, functional proteomics and computer-based modeling to determine whether drugs with well-known targets may be repurposed for use against other biological targets

IBS scientists at the Center for Self-Assembly and Complexity, within the Institute for Basic Science (IBS), invented a hydrogel to fight rheumatoid arthritis and other diseases.